These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26280178)

  • 1. Analysis of a cancer dormancy model and control of immuno-therapy.
    Sheller B; D'Alessandro D
    Math Biosci Eng; 2015 Oct; 12(5):1037-53. PubMed ID: 26280178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.
    de Pillis LG; Gu W; Radunskaya AE
    J Theor Biol; 2006 Feb; 238(4):841-62. PubMed ID: 16153659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines.
    Chekhun VF
    Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
    [No Abstract]   [Full Text] [Related]  

  • 4. A switching control law approach for cancer immunotherapy of an evolutionary tumor growth model.
    Doban AI; Lazar M
    Math Biosci; 2017 Feb; 284():40-50. PubMed ID: 27665680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell-based cellular vaccine: An efficient immunotherapeutic strategy for human malignancies.
    Zhou L; Xiang J; Chen X
    Med Hypotheses; 2011 Feb; 76(2):206-7. PubMed ID: 20974521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization.
    Kogan Y; Halevi-Tobias K; Elishmereni M; Vuk-Pavlović S; Agur Z
    Cancer Res; 2012 May; 72(9):2218-27. PubMed ID: 22422938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.
    Joshi B; Wang X; Banerjee S; Tian H; Matzavinos A; Chaplain MA
    J Theor Biol; 2009 Aug; 259(4):820-7. PubMed ID: 19446568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the efficacy of cancer immunotherapy.
    Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; Håkansson L
    Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour suppression by immune system through stochastic oscillations.
    Caravagna G; d'Onofrio A; Milazzo P; Barbuti R
    J Theor Biol; 2010 Aug; 265(3):336-45. PubMed ID: 20580640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
    Castiglione F; Piccoli B
    Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The capacity of the immune system to control cancer.
    Håkansson L
    Eur J Cancer; 2009 Aug; 45(12):2068-70. PubMed ID: 19608409
    [No Abstract]   [Full Text] [Related]  

  • 13. Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.
    Konstorum A; Vella AT; Adler AJ; Laubenbacher RC
    J R Soc Interface; 2017 Jun; 14(131):. PubMed ID: 28659410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How immunotherapy can enhance the response to other modalities and improve outcome and quality of life.
    Liu WM; Meyer B; Dalgleish AG
    J BUON; 2009 Sep; 14 Suppl 1():S103-9. PubMed ID: 19785052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat.
    Torabi-Rahvar M; Bozorgmehr M; Jeddi-Tehrani M; Zarnani AH
    Drug Discov Today; 2011 Aug; 16(15-16):733-40. PubMed ID: 21558016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dormant tumor cells as a therapeutic target?
    Quesnel B
    Cancer Lett; 2008 Aug; 267(1):10-7. PubMed ID: 18384938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
    Romero I; Garrido F; Garcia-Lora AM
    Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of tumor growth in dendritic cell-based immunotherapy using artificial neural networks.
    Mehrian M; Asemani D; Arabameri A; Pourgholaminejad A; Hadjati J
    Comput Biol Chem; 2014 Feb; 48():21-8. PubMed ID: 24291489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Various ways to improve whole cancer cell vaccines.
    Cicchelero L; de Rooster H; Sanders NN
    Expert Rev Vaccines; 2014 Jun; 13(6):721-35. PubMed ID: 24758597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.